Changes in luteinizing hormone and prolactin control mechanisms produced by glutamate lesions of the arcuate nucleus.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D002369:Castration; D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004958:Estradiol / Q000494:pharmacology; D005260:Female; D005971:Glutamates / Q000494:pharmacology*; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects* / Q000502:physiology; D007986:Luteinizing Hormone / Q000097:blood / Q000502:physiology*; D008297:Male; D010903:Pituitary Gland, Anterior / Q000187:drug effects; D011247:Pregnancy; D011388:Prolactin / Q000097:blood / Q000502:physiology*; D011389:Prolactin Release-Inhibiting Factors / Q000378:metabolism; D051381:Rats; D012970:Sodium Glutamate / Q000494:pharmacology*
D005971:Glutamates; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D011388:Prolactin; D007986:Luteinizing Hormone; D011389:Prolactin Release-Inhibiting Factors; D006916:5-Hydroxytryptophan; D002746:Chlorpromazine; D004298:Dopamine; D012970:Sodium Glutamate